HealthPhoto: Mint CompaniesZumutor Biologics Develops Cancer Drug Activating Natural Killer Cells
Zumutor Biologics is developing a novel cancer drug that activates natural killer cells to fight cancer. Their lead candidate is currently in phase 1 clinical trials. The startup aims to translate early clinical trial signals into a licensing agreement and generate returns for investors, marking a significant step in cancer immunotherapy development.
Mint Companies·



